Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Scientists have discovered that earwax may hold clues to early Parkinson's detection. Analyzing volatile organic compounds ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic mutation.

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Scientists from the University of Copenhagen have uncovered a critical clue about what causes Parkinson’s disease, offering ...

By focusing on twins and patients with lupus and Parkinson’s disease, a Mexican consortium is generating critical data to ...

Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and ...

While the research is still in early stages, it’s an exciting step forward. Most current treatments for Parkinson’s only help ...